Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
Ajouter des filtres








Gamme d'année
1.
Indian J Pathol Microbiol ; 2023 Sept; 66(3): 659-660
Article | IMSEAR | ID: sea-223506
2.
Braz. j. med. biol. res ; 48(3): 226-233, 03/2015. graf
Article Dans Anglais | LILACS | ID: lil-741251

Résumé

Peroxisome proliferator activator receptor-gamma (PPARγ) is a ligand-activated transcriptional factor involved in the carcinogenesis of various cancers. Insulin-like growth factor-binding protein-3 (IGFBP-3) is a tumor suppressor gene that has anti-apoptotic activity. The purpose of this study was to investigate the anticancer mechanism of PPARγ with respect to IGFBP-3. PPARγ was overexpressed in SNU-668 gastric cancer cells using an adenovirus gene transfer system. The cells in which PPARγ was overexpressed exhibited growth inhibition, induction of apoptosis, and a significant increase in IGFBP-3 expression. We investigated the underlying molecular mechanisms of PPARγ in SNU-668 cells using an IGFBP-3 promoter/luciferase reporter system. Luciferase activity was increased up to 15-fold in PPARγ transfected cells, suggesting that PPARγ may directly interact with IGFBP-3 promoter to induce its expression. Deletion analysis of the IGFBP-3 promoter showed that luciferase activity was markedly reduced in cells without putative p53-binding sites (-Δ1755, -Δ1795). This suggests that the critical PPARγ-response region is located within the p53-binding region of the IGFBP-3 promoter. We further demonstrated an increase in PPARγ-induced luciferase activity even in cells treated with siRNA to silence p53 expression. Taken together, these data suggest that PPARγ exhibits its anticancer effect by increasing IGFBP-3 expression, and that IGFBP-3 is a significant tumor suppressor.


Sujets)
Adulte , Femelle , Humains , Mâle , Asthme/induit chimiquement , Gènes MHC de classe I/génétique , Gènes MHC de classe II/génétique , Isocyanates/toxicité , Maladies professionnelles/induit chimiquement , Exposition professionnelle/effets indésirables , Asthme/génétique , Variation génétique , Génotype , Maladies professionnelles/génétique , Polymorphisme de nucléotide simple , Risque
3.
Journal of Surgical Academia ; : 1-1, 2012.
Article Dans Anglais | WPRIM | ID: wpr-629261

Résumé

Basilic vein transposition is a feasible and a good method to make AVF with autogenous vein. Small incision can be applied to basilic vein transposition, which can be less painful and more comfortable to the patients.

SÉLECTION CITATIONS
Détails de la recherche